# TelosRX vs Oak (Oak Longevity): GLP-1 Weight Loss Compared

**By TelosRX Team** · 2026-07-07

**TelosRX and Oak — legally Oak Longevity, and not to be confused with the unrelated Medicare primary-care chain "Oak Street Health" — both run fully asynchronous compounded GLP-1 programs with no mandatory video visit. Both also lead with low headline pricing, so the comparison largely comes down to plan structure and what's included at each price point.**

The short answer

TelosRX's compounded semaglutide starts at $99/month, with microdosed tirzepatide from $116/month and standard tirzepatide from $139/month. Oak Longevity advertises semaglutide from $133/month and tirzepatide from $199/month, with a price-match guarantee and no membership fees. Both are fully async with no mandatory video visit and both claim same-day-to-hours provider turnaround — so it's worth comparing what's bundled at each price before deciding.

[Start your intake →](https://start.telosrx.com/start-online-visit/weightloss)

## Quick comparison: TelosRX vs Oak

Feature

TelosRX

Oak (Oak Longevity)

Model

Fully async, online-first telehealth

Fully async — online questionnaire and doctor review, no mandatory video visit

GLP-1 medications

Compounded tirzepatide & semaglutide, plus oral and microdosed tirzepatide options

Compounded semaglutide & tirzepatide

Starting price

From $99/mo (compounded semaglutide) ✓

Semaglutide from $133/mo; tirzepatide from $199/mo

Pricing transparency

Full tier pricing published on site ✓

Starting price published; advertises price-matching and no membership fees

Provider review/care model

Licensed provider review, often within hours

Doctor review; same-day approval claimed, no mandatory video visit

Support/coaching

Unlimited care-team messaging, quarterly labs ✓

Not publicly detailed on their site; no membership fees advertised

Shipping

Free 48-hour shipping ✓

Not publicly detailed on their site

Cancel policy

Cancel anytime ✓

Not publicly detailed; no membership fees advertised

_Note: Compounded tirzepatide and compounded semaglutide are not FDA-approved medications. They are prepared by licensed pharmacies under federal and state compounding regulations. This comparison covers compounded GLP-1 telehealth programs, not the branded, patented medications themselves._

## What is TelosRX?

TelosRX is an online-first, asynchronous telehealth practice built specifically around compounded GLP-1 weight-management medications. Instead of booking a video call and waiting for an open slot, patients complete a short intake questionnaire online — typically in about five minutes — covering medical history, current medications, and weight-loss goals. A licensed provider reviews that intake and, if appropriate, issues an approval and prescription, often within hours rather than days. There's no mandatory video visit and no waiting room; the front door of the process happens on your schedule.

Once approved, patients can choose compounded [tirzepatide](https://www.telosrx.com/pages/tirzepatide) or compounded [semaglutide](https://www.telosrx.com/pages/semaglutide), the two active ingredients behind the FDA-approved brand-name GLP-1/GIP medications. TelosRX's versions are prepared by licensed compounding pharmacies under federal compounding regulations rather than manufactured by the original branded drugmakers, which is part of what allows TelosRX to offer them at a lower cash price. Dosing is titrated by a provider based on how each patient responds and tolerates the medication, and prescriptions ship directly to the patient's door.

TelosRX is LegitScript-certified, a distinction that verifies the pharmacy network and prescribing practices meet recognized standards for online pharmacies. Plans are cash-pay but FSA/HSA-eligible, and pricing is published in full on the website rather than disclosed only after a lead form — including compounded semaglutide starting at $99/month, microdosed tirzepatide starting at $116/month, and standard tirzepatide starting at $139/month. Patients who want a lower starting dose can also review [oral tirzepatide](https://www.telosrx.com/pages/oral-tirzepatide) and [microdosed tirzepatide](https://www.telosrx.com/pages/microdosed-tirzepatide) options. [Start your online visit](https://start.telosrx.com/start-online-visit/weightloss) to see which plan and dose a provider recommends for you.

## What is Oak?

Oak (oaklovesyou.com) is the trade name of Oak Longevity, a telehealth company offering compounded semaglutide and tirzepatide. It's worth clarifying up front: Oak Longevity is not affiliated with "Oak Street Health," an unrelated Medicare-focused primary-care chain — the shared name is a coincidence, not a connection, and the two companies operate completely different businesses.

Oak's process is fully asynchronous: patients complete an online questionnaire, a doctor reviews it, and there's no mandatory video visit built into the standard path. Oak advertises same-day approval as part of that async model, aiming to get patients from questionnaire to prescription quickly without a scheduled call.

On pricing, Oak advertises semaglutide starting from $133/month and tirzepatide starting from $199/month. The company also promotes a price-match guarantee and states there are no membership fees, positioning its headline pricing as a core part of its pitch to cost-conscious patients.

## Medications: what each program offers

Both TelosRX and Oak prescribe compounded versions of the same two active ingredients: semaglutide and tirzepatide. These are GLP-1 receptor agonists (tirzepatide also acts on the GIP receptor), a medication class that works by slowing digestion, increasing feelings of fullness, and helping regulate appetite and blood sugar. The FDA has approved brand-name versions of these ingredients for chronic weight management — read more from the [National Institute of Diabetes and Digestive and Kidney Diseases](https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity) and the [FDA's announcement on chronic weight-management medications](https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management). Because both TelosRX and Oak dispense compounded — not brand-name — versions, individual results vary and neither program should be compared to clinical trial data generated on the patented, FDA-approved drugs.

TelosRX offers a wider range of formats within its own program — standard, oral, and microdosed tirzepatide alongside semaglutide — all with fully published tiered pricing. Oak's offering is more streamlined: semaglutide and tirzepatide at two headline starting prices, backed by a price-match guarantee rather than a broad menu of formats.

**Key takeaway:** Both TelosRX and Oak run fast, fully async programs with no mandatory video visit. TelosRX's published tirzepatide pricing from $139/month undercuts Oak's advertised tirzepatide starting price of $199/month, while Oak counters with a price-match guarantee and no membership fees.

## Pricing and transparency

TelosRX publishes its full pricing structure directly on its site:

-   Compounded semaglutide from $99/month
-   Microdosed tirzepatide from $116/month
-   Needle-free oral tirzepatide from $129/month
-   Standard tirzepatide from $139/month

Oak advertises semaglutide from $133/month and tirzepatide from $199/month, along with a price-match guarantee and no membership fees. Oak's pricing structure beyond these headline starting numbers — such as dose-tier breakdowns — is not detailed in the same tiered format TelosRX publishes.

## How the process works

Both programs are built to avoid scheduled appointments. TelosRX's process starts with a roughly five-minute online intake questionnaire, reviewed asynchronously by a licensed provider, with approvals commonly issued within hours. Oak's process is also fully async — an online questionnaire reviewed by a doctor, with no mandatory video visit, and same-day approval advertised for patients who qualify.

## Guarantees and ongoing support

TelosRX's ongoing support includes unlimited messaging with the care team and quarterly labs to monitor progress, with the ability to cancel anytime. Oak's standout feature is its price-match guarantee combined with no membership fees — a structure aimed at patients who want to lock in a competitive price without recurring membership costs layered on top of the medication itself.

## Safety and medical oversight

With any GLP-1 program, approval isn't automatic. A licensed provider reviews each patient's intake and medical history, screening for factors such as a personal or family history of medullary thyroid cancer, pancreatitis, and pregnancy, among other contraindications. Nausea and other gastrointestinal side effects are common, especially early in treatment or after a dose increase. Approval is never guaranteed, and patients should disclose their full medical history so a provider can make an informed decision.

## Which service is right for you?

Recommended

### TelosRX

Best for patients who want the lowest published starting price, a full menu of dose formats, quarterly labs, and unlimited care-team messaging.

[Start your intake →](https://start.telosrx.com/start-online-visit/weightloss)

### Oak (Oak Longevity)

May suit patients drawn to a price-match guarantee and no membership fees, with same-day async approval.

Want the lowest published starting price on a fully async compounded GLP-1 plan? [Start your online visit with TelosRX](https://start.telosrx.com/start-online-visit/weightloss) today.

## Frequently Asked Questions

### Is TelosRX legitimate?

Yes. TelosRX is LegitScript-certified, meaning its pharmacy network and prescribing practices have been reviewed against recognized standards for online pharmacies.

### Are the medications FDA-approved?

No. TelosRX dispenses compounded tirzepatide and compounded semaglutide, which are not FDA-approved products. They are prepared by licensed pharmacies under federal and state compounding regulations. The same is true of Oak's compounded medications.

### How much does TelosRX cost vs Oak?

TelosRX starts at $99/month for compounded semaglutide, with microdosed tirzepatide from $116/month and standard tirzepatide from $139/month. Oak advertises semaglutide from $133/month and tirzepatide from $199/month, backed by a price-match guarantee and no membership fees.

### Is TelosRX fully online?

Yes. TelosRX operates as an asynchronous, online-first telehealth service — intake, provider review, and prescription happen without a mandatory video visit, similar to Oak's fully async model.

### Can I switch from Oak to TelosRX?

Yes. You can complete TelosRX's online intake and share your current medication and dosing history for provider review, the same as any new patient.

### How fast is provider review?

TelosRX intake is typically reviewed by a licensed provider within hours. Oak advertises same-day approval as part of its fully async questionnaire-and-doctor-review model.

_TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Ready to get started? [Visit TelosRX](https://telosrx.com) to begin your intake today.

**Tags:** compounded GLP-1, GLP-1, Oak Longevity alternative, semaglutide, TelosRX vs Oak, tirzepatide, weight loss

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/telosrx-vs-oak)
